2020

1. Filanesib for the treatment of multiple myeloma

   Expert Opinion on Investigational Drugs, Vol. 29, Núm. 1, pp. 5-14

2. Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma

   Haematologica

3. Protein translation inhibition is involved in the activity of the pan-pim kinase inhibitor pim447 in combination with pomalidomide-dexamethasone in multiple myeloma

   Cancers, Vol. 12, Núm. 10, pp. 1-20